Soft Tissue Repair Market Segments and Growth by 2025

[Research Report] The soft tissue repair market size is expected to grow from US$ 4,076.2 million in 2019 to US$ 6,677.0 million by 2025; it is estimated to record a CAGR of 8.3% from 2020 to 2025.

Analyst Perspective

The aging population and sports injuries are expected to grow at a lucrative rate over the forecast period. Soft tissue injury can occur during sports and exercise activities, and sometimes daily activities can also cause these injuries. Soft tissue repair refers to a series of procedures in which the soft tissues are regenerated and reconstructed using various medical devices. The rising geriatric population worldwide is increasing the usage of orthopedic soft tissue repair procedures. A rise in awareness of such injuries and the company's efforts towards launching soft tissue repair products are projected to contribute to the growth of the global soft tissue repair market. In May 2022, Paragon 28, Inc. launched Grappler Suture Anchor System to address the challenges arising while performing soft tissue tensioning and ligament reconstruction in acute foot and ankle procedures. Additionally, the presence of highly advanced medical care facilities and high healthcare expenditure are boosting the soft tissue repair market growth in various regions.

Market Overview

Skin, tendons and ligaments, synovial tissue in joints, blood vessels, lymph vessels, peripheral nerves, muscles, nerves, and blood vessels are various types of soft tissue in the human body. Strain, a stretched or torn muscle and/or tendon, a torn or stretched ligament, contusion or bruise, tendinitis, and bursitis are common soft tissue injuries that are most prevalent among athletes and sportsmen. Soft tissue repair involves the use of fixation devices and tissue mesh or patches. Sutures, suture anchors, and interference screws are some of the fixation devices used for soft tissue fixation. Synthetic meshes, allografts, and xenografts are also used to replace the lost soft tissue in various body parts. There is an increase in the demand for soft tissue repair instruments due to an increase in the number of soft tissue injuries among adults and children and the availability of emergency treatment in hospitals. The primary drivers of the soft tissue repair market are increasing incidence of sports injuries and the growing number of orthopedic procedures. Also, increasing focus on sports medicine and soft tissue injury contributes to the growth of the soft tissue repair market.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Get FREE CUSTOMIZATION

Soft Tissue Repair Market: Strategic Insights

• Get Top Key Market Trends of this report.
  This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Free Sample PDF

 

Market Driver

Rising Prevalence of Sports Injuries to Drive Global Soft Tissue Repair Market Growth

There has been an increase in the number of soft tissue injuries among children, adults, and geriatric population. Soft tissue injuries are also common among sportsmen and athletes, which may require immediate treatment. The Center of Disease Control and Prevention (CDC) stated that there is an increase in the number of adults and teenagers participating in sports. As per The Johns Hopkins University, sports injuries are common among adults and children engaged in various sports activities such as football, basket, soccer, ice hockey, and other games as well as athletics. Sprains and strains, knee injuries, tendon injuries, fractures, dislocations, and rotator cuff injuries are some of the common sports injuries.

The prevalence of sports injuries is rising due to the increasing number of adults participating in sports. Government organizations carry out surveys to determine the number of common sports injuries in a particular area that needs to be addressed. As per the data by The National Safety Council, children aged 5-14 years account for 50% of all football injuries, 45% of soccer injuries, and 44% of baseball injuries. Football caused the most injuries, with ~455,449 cases yearly in 2018-19. Of all the knee injuries experienced due to football, the most common is a rupture of the anterior cruciate ligament (ACL). Soccer caused ~412,607 injuries (in both male and female players) in the same year; an estimated 22% of these injuries are concussions. In 2021, nearly 57,600 sports-related injuries were concussions. Additionally, about 3.2 million people were treated in emergency departments for injuries involving sports and recreational equipment in 2021.

Contact sports such as basketball and football possess a higher rate of sports injuries as these sports involve contact and collision, leading to severe injuries to joints, bones, tendons, and other soft tissues. Such injuries require emergency treatment or even a surgical procedure. As per ValuePenguin research data, more than 4.4 million basketball-related injuries were treated at emergency departments in 2021. Following that, football was the second most common sport leading to injury and caused 3.3 million injuries, accounting for 20% of all sports-related injuries. According to the American Academy of Orthopaedic Surgeons, an estimated. 2,00,000 ACL injuries are reported annually in the US, with around 1,00,000 ACL reconstructions performed yearly. Thus, the number of sports-related soft tissue injuries is increasing, which in turn drives the growth of the soft tissue repair market.

Segmental Analysis

Based on product, the soft tissue repair market is segmented into fixation instruments and tissue mesh/patch. In 2019, the fixation instruments segment held a larger share of the soft tissue repair market. Also, the same segment is estimated to register a higher CAGR during the forecast period. During soft tissue repair, various fixation devices are used to fix the soft tissue to the surface of anatomical structures, such as the bone, which has more strength and stiffness than soft tissue. Suture, suture anchor, interference screw, and others are the major fixation device types used in various orthopedic procedures. These devices enable the physician to maintain tissue tension during surgical procedures. The fixation instruments segment is sub-segmented into suture anchors, interference screws, sutures, and others. The sutures anchors segment held the largest share of the market in 2019 and is estimated to register the highest CAGR during the forecast period. Sutures anchors are used for soft tissue fixation, especially during arthroscopic and hernia repair surgery. Newly available and technologically advanced anchors are now used for repairing and optimizing musculoskeletal tissues such as the hip, knee, hand, elbow, foot, and ankle. Suture anchors help in soft tissue-to-bone healing as direct soft tissue-to-soft-tissue repair is not possible due to the inadequate amount of soft tissue on the bone. In addition, various sutures anchors in the soft tissue repair market offer strong and improved fixation. A knotless suture anchor helps to secure soft tissue to a rigid structure such as bone. The inner member of the anchor receives suture thread and rotates within an outer tubular member. Due to the rotation of the inner membrane of the anchor, the suture thread is wrapped onto the inner member. The outer tubular membrane applies pressure on the thread attached to retain the thread's position on the inner membrane, thereby enabling suturing of the tissue.

Regional Analysis

The North America soft tissue repair market was valued at US$ 1,791.50 million in 2019 and is projected to reach US$ 2,994.6 million by 2025; it is expected to grow at a CAGR of 8.7% during the forecast period. The North America soft tissue repair market is segmented into the US, Canada, and Mexico. The US held the largest share of the North American soft tissue repair market in 2019. The growth of the soft tissue repair market in the country is primarily driven by increasing usage of biologics for soft tissue repair and orthopedic procedures such as hernia repair. Allografts are mostly used for tissue repair in the US due to general preference of surgeons towards the use of allografts. As per the Ortho Regenerative Technologies, nearly 600,000 rotator cuff surgeries are performed each year in the US. As per the American Orthopedic Society for Sports Medicine, nearly 100,000 to 250,000 ACL ruptures annually in the US. Also, tissue injuries have received significant importance, leading to increasing awareness about soft tissue injuries and their treatment among athletes. Additionally, breast cancer is also prevalent among the women in the country. As per the data from breastcancer.org, nearly 1 in 8 women (about 12.4%) will develop invasive breast cancer during their lifetime in the US. As of January 2022, more than 3.8 million women have breast cancer in the country. As per the American Society of Plastic Surgeons (ASPS)/Plastic Surgery Foundation 2020 data, ~101,600 women in the US went through breast reconstruction in 2018.

Moreover, new product launches and funding for research purposes also drive the soft tissue repair market growth in the US. For instance, in November 2022, Novadip Biosciences raised an additional US$ 41.03 million (EUR 40 million) in a Series B equity round and non-dilutive funding. The funding accelerated the clinical development of two of Novadip’s investigational adipose stem cell (ASC)-derived tissue regeneration products: NVD-X3 and NVD-003. Thus, above mentioned factors are expected to propel the soft tissue repair market growth in the North American region.

Key Player Analysis

The soft tissue repair market analysis consists of players, such as Smith & Nephew; Depuy Synthes; Covidien (Medtronic); Wright Medical Group, Inc.; C.R Bard, Inc.; Arthrex, Inc.; Integra Lifesciences Corporation; Organogenesis; Stryker; and ConMed. Among the players in the soft tissue repair market, Depuy Synthes and Arthrex, Inc are the top two players owing to the diversified product portfolio offered.

Soft Tissue Repair Market Regional Insights

The regional trends and factors influencing the Soft Tissue Repair Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Soft Tissue Repair Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Soft Tissue Repair Market Report Scope

Soft Tissue Repair Market Players Density: Understanding Its Impact on Business Dynamics

The Soft Tissue Repair Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

Major Companies operating in the Soft Tissue Repair Market are:

1. Smith & Nephew
2. DePuy Synthes
3. Arthrex, Inc.
4. Medtronic
5. Integra Lifesciences Corporation

Disclaimer: The companies listed above are not ranked in any particular order.

Recent Developments

Inorganic and organic strategies such as mergers and acquisitions are highly adopted by companies in the soft tissue repair market. A few recent key market developments are listed below: 

• In January 2023, Arthrex’s ACL TightRope implant received clearance from the US Food and Drug Administration (FDA) for pediatric indications. The TightRope implant is used in the surgical treatment of orthopedic injuries and is the first and only fixation device for ACL injuries cleared for pediatric use.
• In August 2022, CONMED Corporation completed the acquisition of privately held Biorez, Inc (a medical device start-up focused on advancing the healing of soft tissue using its proprietary BioBrace Implant technology). The BioBrace Implant is an innovative bio-inductive scaffold intended to reinforce soft tissue and facilitate healing. The acquisition was settled on cash consideration of US$85 million at closing and up to an additional US$165 million in growth-based earnout payments over four years.
• In September 2021, Stryker’s Trauma & Extremities division launched its Citrelock Tendon Fixation Device System to provide surgeons with a differentiated design via a tendon thread featuring a resorbable technology called Citregen.
• In July 2021, BD acquired Tepha, Inc., a leading developer and manufacturer of proprietary resorbable polymer technology. Tepha's Poly 4-hydroxybutyric acid, P4HB technology platform provides additional innovation potential that accelerates the growth of BD's surgical mesh portfolio and drives the company into potential new areas within soft tissue repair, reconstruction, and regeneration.